Penile Mondor's in a Covid-19 patient on prophylactic anti-thrombosis with rivaroxaban: a case report.

Murat Tuğrul Eren Hakan Özveri Hilal Kurtoğlu

Published in: African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA) (2021)

Low-dose Rivaroxaban 15 mg is not safe for some COVID-19-associated thromboembolism prophylaxis, and careful follow-up is critical due to the possibility of a wide range of pathologic thrombotic manifestations in COVID-19 infection.

Keyphrases

coronavirus disease
pulmonary embolism
sars cov
low dose
venous thromboembolism
atrial fibrillation
high dose
case report
neoadjuvant chemotherapy
respiratory syndrome coronavirus
radical prostatectomy
locally advanced